EUVIMEDEUVIMED entdecken
Crossref

Harnessing CRISPR-Cas9 fidelity for therapeutic genome editing: from off-target mechanisms to delivery design

Dowoon Gu, Mingyo Park

KOBRA Reports · 02.11.2026 · 2

DOI: 10.64066/kobrareports.26.0020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift KOBRA Reports, online erschienen am 02.11.2026. Verfasst von Dowoon Gu und 1 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Ministry of Education.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-Cas9, an RNA-guided immune system adapted for genome editing, enables sequence-specific DNA cleavage through a programmable guide RNA (gRNA).This programmability has expanded therapeutic genome editing across diverse disease contexts, and the first CRISPR-Cas9-based therapy (Casgevy) has now been approved.However, Cas9 tolerates partial mismatches between the gRNA and the genomic target, and the resulting off-target cleavage can introduce mutations, large deletions, and chromosomal rearrangements.Off-target effects further depend on the dose, persistence, and tissue distribution of the active Cas9-gRNA complex.Over the past decade, sensitive detection methods, along with Cas9 and gRNA engineering, have substantially improved editing precision, supporting safer therapeutic translation.In this review, we discuss the mechanism of off-target cleavage and the strategies developed to mitigate it, including high-fidelity Cas9 variants, chemically and structurally modified gRNAs, and delivery formats.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea
  • Ministry of Education
  • Korean Biomedical Research Alliance

Zitieren

APA

Gu, D., & Park, M. (2026). Harnessing CRISPR-Cas9 fidelity for therapeutic genome editing: from off-target mechanisms to delivery design. KOBRA Reports, 2. https://doi.org/10.64066/kobrareports.26.0020

Vancouver

Gu D, Park M. Harnessing CRISPR-Cas9 fidelity for therapeutic genome editing: from off-target mechanisms to delivery design. KOBRA Reports. 2026;2. doi:10.64066/kobrareports.26.0020

BibTeX
@article{Gu2026,
  author = {Gu, Dowoon and Park, Mingyo},
  title = {Harnessing CRISPR-Cas9 fidelity for therapeutic genome editing: from off-target mechanisms to delivery design},
  journal = {KOBRA Reports},
  year = {2026},
  volume = {2},
  doi = {10.64066/kobrareports.26.0020}
}
Kostenlos starten →